Variation in prostate cancer assessment and management between Māori and non-Māori in New Zealand

IF 3.7 2区医学 Q1 UROLOGY & NEPHROLOGY

BJU International Pub Date : 2025-06-13 DOI:10.1111/bju.16805

Eng Ann Toh, Jared White, Judith Clarke, Phil Hider, Stephen Mark

引用次数: 0

Abstract

To identify possible causes for inequitable prostate cancer (PCa) outcomes in Māori by examining any differences in the assessment and management of Māori and non-Māori diagnosed with PCa in Aotearoa New Zealand (NZ).

查看原文本刊更多论文

新西兰Māori和non-Māori之间前列腺癌评估和管理的差异

通过检查新西兰Aotearoa （NZ）诊断为前列腺癌的Māori和non-Māori在评估和管理方面的任何差异，确定Māori中前列腺癌（PCa）结果不公平的可能原因。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BJU International 医学-泌尿学与肾脏学

CiteScore

9.10

自引率

4.40%

发文量

262

审稿时长

1 months

期刊介绍： BJUI is one of the most highly respected medical journals in the world, with a truly international range of published papers and appeal. Every issue gives invaluable practical information in the form of original articles, reviews, comments, surgical education articles, and translational science articles in the field of urology. BJUI employs topical sections, and is in full colour, making it easier to browse or search for something specific.